These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2180397)

  • 81. Lack of a persistent reduction in serum lipid and apoprotein levels in insulin-dependent diabetic patients receiving intensified insulin treatment.
    Goldberg RB; Reeves ML; Seigler DE; Ryan EA; Miller N; Hsia SL; Skyler JS
    Acta Diabetol Lat; 1985; 22(2):93-101. PubMed ID: 3907233
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Serum lipids and apoprotein composition (%) of the very low density lipoprotein (VLDL) fraction in two groups of diabetic patients: effects of oral as compared to insulin therapy.
    Pagnan A; Padovan D; Guarini P; Teodoro N; Zanetti G
    Acta Diabetol Lat; 1980; 17(3-4):225-8. PubMed ID: 7013397
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A randomized cross-over study of the effects of proinsulin on lipid metabolism in type 2 diabetes.
    Winocour PH; Mallik TH; Ishola M; Baker RD; Bhatnagar D; Durrington PN; Anderson DC
    Diabet Med; 1991 Jan; 8(1):22-7. PubMed ID: 1826239
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Racial differences in lipid and lipoprotein levels in diabetes.
    Summerson JH; Konen JC; Dignan MB
    Metabolism; 1992 Aug; 41(8):851-5. PubMed ID: 1640862
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Plasma lipoproteins in maturity onset diabetes.
    Mancini M; Rivellese A; Rubba P; Riccardi G
    Nutr Metab; 1980; 24 Suppl 1():65-73. PubMed ID: 7454139
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Comparison of plasma lipoproteins and apoproteins in Chinese and American non-insulin-dependent diabetic subjects and controls.
    Pan XR; Walden CE; Warnick GR; Hu SX; Albers JJ; Cheung M; Bierman EL
    Diabetes Care; 1986; 9(4):395-400. PubMed ID: 3743315
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Dysfunctional HDL and atherosclerotic cardiovascular disease.
    Rosenson RS; Brewer HB; Ansell BJ; Barter P; Chapman MJ; Heinecke JW; Kontush A; Tall AR; Webb NR
    Nat Rev Cardiol; 2016 Jan; 13(1):48-60. PubMed ID: 26323267
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Comparing the effects of insulin glargine and thiazolidinediones on plasma lipids in type 2 diabetes: a patient-level pooled analysis.
    Chaudhuri A; Rosenstock J; DiGenio A; Meneghini L; Hollander P; McGill JB; Dandona P; Ilgenfritz J; Riddle M
    Diabetes Metab Res Rev; 2012 Mar; 28(3):258-67. PubMed ID: 22081557
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Why is HDL functionally deficient in type 2 diabetes?
    Kontush A; Chapman MJ
    Curr Diab Rep; 2008 Feb; 8(1):51-9. PubMed ID: 18366999
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Mechanisms underlying lysophosphatidylcholine-induced potentiation of vascular contractions in the Otsuka Long-Evans Tokushima Fatty (OLETF) rat aorta.
    Matsumoto T; Kobayashi T; Kamata K
    Br J Pharmacol; 2006 Dec; 149(7):931-41. PubMed ID: 17031383
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Retinal pigment epithelial acid lipase activity and lipoprotein receptors: effects of dietary omega-3 fatty acids.
    Elner VM
    Trans Am Ophthalmol Soc; 2002; 100():301-38. PubMed ID: 12545699
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Postprandial triglyceride metabolism in diabetes mellitus.
    Georgopoulos A
    Clin Cardiol; 1999 Jun; 22(6 Suppl):II28-33. PubMed ID: 10376194
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Effects of hydrochlorothiazide and captopril on lipoprotein lipid composition in patients with essential hypertension.
    Bagdade JD; Buchanan WF; Pollare T; Lithell H
    Eur J Clin Pharmacol; 1996; 49(5):355-9. PubMed ID: 8866628
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).
    Wolffenbuttel BH; van Haeften TW
    Drugs; 1995 Aug; 50(2):263-88. PubMed ID: 8521759
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The effect of low density lipoprotein composition on the regulation of cellular cholesterol synthesis: a comparison in diabetic and non-diabetic subjects.
    Owens D; McBrinn S; Collins P; Johnson A; Tomkin GH
    Acta Diabetol; 1993; 30(4):214-9. PubMed ID: 8180413
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients.
    James RW; Pometta D
    Diabetologia; 1991 Apr; 34(4):246-52. PubMed ID: 2065858
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Coronary heart disease in diabetes mellitus--antecedents and associations.
    Winocour PH
    Postgrad Med J; 1991 Oct; 67(792):917-21. PubMed ID: 1758804
    [No Abstract]   [Full Text] [Related]  

  • 98. Persistent abnormalities in lipoprotein composition in noninsulin-dependent diabetes after intensive insulin therapy.
    Bagdade JD; Buchanan WE; Kuusi T; Taskinen MR
    Arteriosclerosis; 1990; 10(2):232-9. PubMed ID: 2180397
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes.
    Taskinen MR; Kuusi T; Helve E; Nikkilä EA; Yki-Järvinen H
    Arteriosclerosis; 1988; 8(2):168-77. PubMed ID: 3279941
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Lipoproteins and apolipoproteins in young nonobese Arab women with NIDDM treated with insulin.
    Al-Muhtaseb N; Al-Yusuf AR; Abdella N; Fenech F
    Diabetes Care; 1989 May; 12(5):325-31. PubMed ID: 2656141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.